← Back
Google DeepMind

AlphaGenome 2: Deciphering how cells read DNA to better understand disease

•9 min read•
#deployment
AlphaGenome 2: Deciphering how cells read DNA to better understand disease
Level:Advanced
For:AI Engineers
✦TL;DR

AlphaGenome 2 is a conditional DNA‑sequence model that predicts the impact of genetic variants on gene expression in specific human cell types and states, improving variant detection nearly two‑fold over its predecessor. Trained on more than 100 million single‑cell profiles spanning 68 tissues, it ingests a 1‑million‑base DNA segment together with a cell‑type condition at every architectural stage. The model is accessible via the AlphaGenome API for non‑commercial research and in private preview for commercial use, enabling engineers to embed cell‑type‑specific variant predictions into genomics pipelines.

⚡ Key Takeaways

  • Identifies nearly twice as many variants that change gene expression in cells compared to AlphaGenome 1.
  • Uses a conditional architecture that incorporates the target biological condition (tissue, cell type, or state) alongside the DNA sequence at each layer.
  • Trained on >100 million individual cell profiles across 68 tissues, providing fine‑grained predictive power.
  • Accessible through the AlphaGenome API for non‑commercial research (private preview for commercial).
  • Requires a 1‑million‑letter DNA sequence input and a defined cell‑type condition; predictions for unseen cell states rely on the model’s encoder.
💡 Why It Matters

Engineers can now integrate precise, cell‑type‑specific variant effect predictions into disease‑association studies and drug‑target pipelines, reducing reliance on coarse bulk‑tissue models and accelerating discovery of cellular disease mechanisms.

✅ Practical Steps

  1. Call the AlphaGenome API with a 1‑million‑base DNA sequence and a cell‑type identifier from the reference catalog to obtain variant effect predictions.
  2. Encode custom single‑cell experiment data using the provided cell encoder to generate on‑the‑fly condition inputs for novel cell states.
  3. Deploy the API calls within your variant‑prioritization workflow to replace bulk‑tissue predictions with cell‑type‑specific scores.

Want the full story? Read the original article.

Read on Google DeepMind ↗

More like this

Introducing workload recovery and expanded infrastructure checks on Amazon SageMaker HyperPod

AWS ML Blog•#deployment

Introducing Unity Gateway Insights

Databricks Blog•#deployment

Introducing Gemini 4 Neon

Google DeepMind•#llm

DaisyRose-27B: Pushing the Frontier of Post-Training Efficiency

Hugging Face Blog•#llm

EXPLORE AI NEWS

Daily hand-picked stories on LLMs, RAG, agents and production AI — curated for engineers who ship.

BROWSE NEWS

GET THE WEEKLY DIGEST

Join engineers getting the Monday signal-over-noise AI breakdown. No spam, unsubscribe anytime.

LEARN AI ENGINEERING

Curated courses, research papers, repos and tutorials built for engineers leveling up in AI.

START LEARNING